|
Volumn 55, Issue 7, 2012, Pages 1020-1021
|
Editorial commentary: Advocating the concept of GB virus C biotherapy against AIDS
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIVIRUS AGENT;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
NONSTRUCTURAL PROTEIN 5A;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BLOOD TRANSFUSION;
CELL DEATH;
DISEASE COURSE;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
GENE PRODUCT;
HEPATITIS G VIRUS;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOSUPPRESSIVE TREATMENT;
MEDICAL RESEARCH;
MIXED INFECTION;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PRIORITY JOURNAL;
SEXUAL TRANSMISSION;
TREATMENT RESPONSE;
VIREMIA;
VIRUS ACTIVATION;
VIRUS LOAD;
VIRUS TRANSMISSION;
FEMALE;
FLAVIVIRIDAE INFECTIONS;
GB VIRUS C;
HEPATITIS, VIRAL, HUMAN;
HIV INFECTIONS;
HUMANS;
MALE;
|
EID: 84866062807
PISSN: 10584838
EISSN: 15376591
Source Type: Journal
DOI: 10.1093/cid/cis591 Document Type: Editorial |
Times cited : (13)
|
References (1)
|